AcelRx Pharma (ACRX) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. ON
5. INSP
6. RXRX
7. VRTX
8. MTCH
9. CVI
10. CHKP

Go back to AcelRx Pharma (ACRX) Reports In-Line Q1 EPS

AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results

May 17, 2021 4:01 PM EDT

HAYWARD, Calif., May 17, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its first quarter 2021 financial results.

"We continue to make solid progress on the commercialization of DSUVIA despite the impact from the pandemic, which appears to be easing as the month of April was our highest commercial ordering month since the launch," said Vince Angotti, Chief Executive Officer of AcelRx. "We remain committed to building the body of... More